Is EXEL a good stock to buy? We came across a bullish thesis on Exelixis, Inc. on TradersPro’s Substack. In this article, we will summarize the bulls’ thesis on EXEL. Exelixis, Inc.’s share was trading at $66.28 as of October 28th 2026. EXEL’s trailing and forward P/E were 20.62 and 15.25 respectively according to Yahoo Finance.
This isn’t the first time we see a drug development company pitched as a great investment. EXEL shares gained 70.21% over the last 12 months. Comparable...
